Predicting Immune Checkpoint Inhibitor-Related Pneumonitis via Computed Tomography and Whole-Lung Analysis Deep Learning.

Journal: Current medical imaging
PMID:

Abstract

BACKGROUND: Immune checkpoint inhibitor-related pneumonitis (ICI-P) is a fatal adverse event of immunotherapy. However, there is a lack of methods to identify patients who have a high risk of developing ICI-P in immunotherapy.

Authors

  • Ning Wang
    Qilu Hospital of Shandong University Dezhou Hospital, Dezhou, Shandong, China.
  • Zhifang Zhao
    The First Medical Center of Chinese PLA General Hospital, Beijing, China.
  • Zhimei Duan
    College of Pulmonary and Critical Care Medicine, Chinese PLA General Hospital, No. No 28, FuXing Road, Beijing 100853, China.
  • Fei Xie
    Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou 510060, China.